Trial Profile
A Single-Center, Open-Label, Pilot Study to Evaluate the Efficacy and Tolerability of Narrow Band UVB Phototherapy in Enhancing Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque-Type Psoriasis.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Nov 2013
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 09 Dec 2009 Planned initiation date changed from 1 Oct 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 20 Oct 2009 New trial record.